Related Experiment Video
Updated: Jun 12, 2026
09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Hypoxia inducible factor-1α in human emphysema lung tissue
M Yasuo1, S Mizuno, D Kraskauskas
1Pulmonary and Critical Care Medicine Division and Victoria Johnson Center for Obstructive Lung Diseases, Virginia Commonwealth University, Richmond, VA, USA.
The European Respiratory Journal
|June 22, 2010
Summary
This study found reduced hypoxia-inducible factor-1α (HIF-1α) protein expression in severe chronic obstructive pulmonary disease (COPD) lung tissue. This decrease correlates with impaired lung structure maintenance at a molecular level.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Cell Biology
Background:
- The pathobiology of chronic obstructive pulmonary disease (COPD) remains incompletely understood.
- Hypoxia-inducible factor 1-alpha (HIF-1α) plays a crucial role in cellular responses to hypoxia and tissue maintenance.
Purpose of the Study:
- To investigate the expression levels of HIF-1α in lung tissue from patients with COPD and emphysema.
- To correlate HIF-1α expression with disease severity and other molecular markers.
Main Methods:
- Analysis of mRNA and protein expression of HIF-1α and histone deacetylase 2 in lung tissue samples from 26 patients (7 controls, 6 moderate COPD, 13 severe COPD).
- Immunohistochemistry was used to localize HIF-1α expression in specific lung cell types.
- Correlation analysis with forced expiratory volume in 1 second (FEV1) and smoking history.
Main Results:
- Significantly decreased expression of HIF-1α and histone deacetylase 2 proteins in COPD patients, with a positive correlation between them.
- HIF-1α protein levels correlated with vascular endothelial growth factor (VEGF) and FEV1 % predicted.
- Reduced HIF-1α protein expression was observed in lung endothelial and alveolar septal cells, independent of age and smoking history.
Conclusions:
- Reduced HIF-1α protein expression in severe COPD suggests an impairment in the molecular mechanisms responsible for lung structure maintenance.
- These findings highlight a potential molecular pathway contributing to the progression of COPD.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...